Pregnancy outcomes good for women with MS

By Amy Norton

NEW YORK (Reuters Health) - Good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A study published Wednesday shows that while women with MS have a somewhat heightened risk of certain pregnancy complications, by and large, their pregnancies are as healthy as other women's.

Using a national database on nearly 19 million deliveries in the U.S., researchers found that women with MS had marginally higher risks of cesarean delivery and intrauterine growth restriction -- where a newborn's weight is below the 10th percentile for his or her gestational age.

Among more than 10,000 women with MS who gave birth between 2003 and 2006, 42 percent had a C-section, compared with roughly 33 percent of women overall. Meanwhile, intrauterine growth restriction was seen in almost 3 percent, versus 2 percent of other women.

Still, the overall findings, published in the medical journal Neurology, are being seen as good news for women with MS -- a disorder that is more prevalent among women of childbearing age than any other group.

"I think these findings are quite reassuring for women with MS," senior researcher Dr. Eliza F. Chakravarty, a rheumatologist at Stanford University School of Medicine in California, told Reuters Health in an email. "We found that the obstetric outcomes for women with MS were not terribly different from those seen in the general population."

MS is believed to arise from an abnormal immune system attack on the body's own myelin, a protective sheath surrounding nerve fibers in the brain and spine. This leads to symptoms such as muscle weakness, numbness, vision problems and difficulty with coordination and balance.

Years ago, women with MS were advised to avoid pregnancy, out of concern that it could exacerbate the disease. But studies in recent decades have shown that the opposite is true; many women see a remission in their symptoms during pregnancy -- possibly because immune system activity naturally declines and levels of anti-inflammatory corticosteroids naturally rise during pregnancy.

Much less has been known, however, about pregnancy complications in women with MS.